Test Price
3,000 AED✅ Home Collection Available
Dementia Panel Genetic Test (NGS) in Dubai – DNA Labs UAE
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Next‑Generation Sequencing
- Comprehensive screening of 50+ dementia-associated genes including APP, PSEN1, PSEN2, MAPT, GRN, and C9orf72
- VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM
- Post-test telephonic clinical guidance included with mandatory genetic counselling session
- Insurance direct billing verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
This comprehensive genetic panel screens for pathogenic variants in over 50 genes associated with Alzheimer's disease, frontotemporal dementia, and other neurodegenerative disorders, enabling early risk stratification and personalised care planning through advanced next-generation sequencing technology.
| Feature | Our Test (Dementia Panel NGS) | Closest Alternative (Standard Single‑Gene) |
|---|---|---|
| Precision & Method | Next‑Generation Sequencing (NGS) covering 50+ dementia‑associated genes with full coding region analysis | Sanger sequencing for 1–3 individual genes (e.g., APP only) |
| Turnaround Time | 3 to 4 weeks | 6–8 weeks |
| Genes Covered | APP, PSEN1, PSEN2, MAPT, GRN, C9orf72 and 45+ others | 1–3 genes per test |
| Interpretation Support | Comprehensive genetic counselling and clinical correlation guidance | Limited to raw variant report |
| Price (AED) | 3,000 | 1,500–2,000 |
Physician Insight & Safety Protocols
"Cognitive decline can be deeply unsettling for both patients and families. This NGS panel offers a window into hereditary risk, but results must always be interpreted within the full context of clinical presentation, family pedigree, and lifestyle factors. A positive finding does not equate to an imminent diagnosis, and a negative result does not eliminate all risk. Genetic counselling before and after testing is essential to ensure informed decision-making."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
⚠ Do not discontinue or adjust any prescribed dementia, psychiatric, or neurological medication based solely on this test result. Always consult your treating physician before making any changes to your medication regimen.
Exclusion Criteria & Emergency Red Flags
- Inability to provide informed consent (refer to legal guardian in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability)
- Acute febrile illness or active infection that may affect sample integrity
- Recent blood transfusion (within 7 days)
- Seek emergency care if: sudden severe confusion, focal weakness, loss of consciousness, or rapid cognitive decline with psychotic features
Patient FAQ & Clinical Guidance
1. What specific genes are included in the Dementia Panel NGS test?
The panel sequences over 50 dementia-linked genes, including APP, PSEN1, PSEN2, MAPT, GRN, and C9orf72, covering hereditary Alzheimer's disease and frontotemporal dementia. This broad coverage enables identification of rare variants that single-gene testing would miss.
2. Is genetic counselling required before undergoing this test?
Yes, a pre-test genetic counselling session is mandatory to construct a family pedigree, discuss inheritance patterns, and assess risk prior to sample collection. Post-test counselling is also provided to help interpret results in the context of your personal and family medical history.
3. How accurate is this test for predicting future Alzheimer's disease?
The NGS panel achieves 99.9% analytical sensitivity for point mutations and small insertions or deletions. However, clinical prediction depends on variant classification, penetrance estimates, and the interplay of genetic, environmental, and lifestyle factors. A genetic finding alone does not determine disease onset with certainty.
UAE Regulatory & Data Privacy Adherence
All genetic data generated through this test is handled in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient information is encrypted, access-controlled, and used solely for diagnostic and clinical counselling purposes. Results are shared only with the requesting physician and the patient with explicit consent.
Clinical & Logistical Metadata
| Test Name | Dementia Panel Genetic Test (NGS) |
| Price (AED) | 3,000 |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM |
| Methodology Used | Next-Generation Sequencing (NGS) – Full coding region analysis of 50+ dementia-associated genes |
| ICD-10-CM Code | Z13.858 (Encounter for screening for other nervous system disorders) |
| LOINC Code | 101349-1 (Alzheimer disease related genes panel) |
| DHA Facility License & Laboratory Address | DHA Facility License #1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians